A B S T R A C T Endogenous thyrotropin-releasing hor
INTRODUCTION
The availability of synthetic thyrotropin-releasing hormone (TRH)1 for clinical investigation has led to the Received for publication 13 (1, 2) , primary hypothyroidism (1, 3, 4) , monotrophic TSH deficiency (5) , and panhypopituitarism (3, 4, 6) . Much (7, 8) . Presumably these patients have a deficiency in endogenous hypothalamic TRH secretion. This is a conclusion which is reached by indirection however, for as yet, no direct measurement of endogenous TRH secretory capacity is possible. Thus, a diagnosis of hypothalamic hypothyroidism is now established by excluding thyroidal and pituitary etiologies.
Recently we have proposed a qualitative method for assessing endogenous TRH and TSH reserve in man (9) . This method is based on the observation that glucocorticoid administration in pharmacologic doses 
METHODS
Study groups 12 subjects were included in this study (see Table I ): Four normal subjects had been referred to our 
Pituitary testing
Growth hormone reserve was determined by the rise in plasma growth hormone in response to insulin-induced hypoglycemia (10) . Growth hormone determinations were performed by a modification of the radioimmunoassay method of Greenwood and Hunter (11) . ACTH reserve was assessed by the rise in the 24 h urinary ketogenic steroid (KGS) excretion following the administration of methopyrapone given orally on a schedule of 750 mg every 4 h for a 2 day period. Urinary KGS excretion was determined by the method of Rutherford and Nelson (12) . When the methopyrapone test was abnormal, the adequacy of adrenal function was verified by measuring urinary 17KGS excretion in response to the intravenous administration of synthetic ACTH. Pituitary gonadotropins were assessed by measurement of urinary bioassayable gonadotropins (13) .
Thyroid testing procedures
Serum TSH values were determined by the double antibody radioimmunoassay technique described by Odell, Wilber, and Utiger (14) . Serum thyroxine was measured by the competitive protein binding method of Murphy and Pattee (15) and free thyroxine estimates by the method of Sterling and Brenner (16) (performed by Bio-Science Laboratories, Van Nuys, Calif). 24-h thyroidal radioactive iodine uptake measurements (RAIU) before and following TSH stimulation were performed in selected cases.
Thyroidal iodine release (TIR) method
A dual iodine isotopic release method was used to measure changes in TIR. This method has been described in detail in previous reports (17, 18 measurements so that 10-15 AiCi would be delivered to the thyroid gland. 50 AGCi of ['Ithyroxine (T4) (specific activity was greater than 40 ,Ci/ig at time of administration) was then given intravenously to serve as a reference isotope. The site of measurement of the thyroid release products was the urine. Urinary ratios of`2 I/P'lI were used to detect changes in TIR. Since T4 is deiodinated at a relatively constant rate (19) Table I ). Fig. 4 demonstrates the loss of overshoot in TIR and a rather slow return to the base-line release slope following glucocorticoid withdrawal in all three of these subjects. While some overshoot is observed in patient J. Z., the degree is small and delayed compared with the normal subjects depicted in Fig. 2 (23) . On the other hand, it has been shown by Sheehan and Stanfield (24) that the lesion in this disorder may occasionally involve only the vascular supply of the pituitary stalk with secondary pituitary insufficiency. Sheehan (23) also has shown that the pituitary gland is capable of some regeneration and proliferation of the parenchyma following vascular necrosis. The fact that pregnancy had occurred in two of our patients, and also has been reported by others (25, 26) , adds sul)-port to the contention that not a simple destructive lesion of the pituitary had occurred in this group, as in the postcryohypophysectomy patients. It would follow then that other pituitary trophic hormone deficiencies in Sheehan's syndrome may involve impaired hypophysiotrophic hormone reserve or transport capacity.
Despite the apparent discrimination provided by the methods employed in this study, certain inherent limitations are evident. The interpretation of the glucocorticoid withdrawal test is at present qualitative in nature. No firm conclusions regarding the amount of suppression by glucocorticoids and the degree of rebound of TIR following glucocorticoid withdrawal can be made by simple inspection of the graphic data. However, we are currently assessing various measurable parameters in order to quantitate the degree of suppression and rebound. These data will be included in a subsequent report. Presently though, it seems evident that the differences in rebound responses in normal subjects and those in patients with pituitary and suprahypophyseal disorders can be appreciated on a qualitative basis. Another methodological limitation is that several weeks of frequent daily urine collections are required as a part of this study procedure. This tends to be somewhat cumbersome and tedious, therefore limiting its potential clinical usefulness.
Possibly the most interesting finding in this study was that euthyroidism could be maintained in spite of impaired endogenous TRH reserve. This was apparent in the patient with the hypothalamic lesion and in two of the four patients with Sheehan's syndrome. Perhaps the wide distribution of TRH in the anterior and basal portions of the hypothalamus, and the compensating nature of the negative feedback action of thyroid hormone on pituitary release of TSH allows for maintenance of a euthyroid state in the presence of this apparent diminished TRH reserve. Recent studies performed in other euthyroid patients with suspected or demonstrated hypothalamic lesions have revealed similar findings (27, 28) . Thus a future major application of the TRH stimulation and glucocorticoid withdrawal tests may be in the detection of patients with abnormal endogenous TRH reserve, in whom adequate TSH reserve and normal peripheral thyroid hormone economy are maintained.
